PROFUND ADVISORS LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 1129919 BETHESDA, MD

Position in COGT

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,788,946

-$406,946 QoQ

Shares Held

46,226

-19.0% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#168

of 321 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. COGT ranks #23 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,788,946	46,226	-19.0%	Shares	Sole	2026-08-11
2026-03-31	$2,195,892	57,051	+33.5%	Shares	Sole	2026-04-27
2025-12-31	$1,518,444	42,749	+29.2%	Shares	Sole	2026-02-06
2025-09-30	$475,071	33,083	+64.1%	Shares	Sole	2025-11-06
2025-06-30	$144,727	20,157	-42.2%	Shares	Sole	2025-08-07
2025-03-31	$209,021	34,895	+10.5%	Shares	Sole	2025-05-08
2024-12-31	$246,394	31,589	+34.9%	Shares	Sole	2025-02-14
2024-09-30	$252,957	23,422	-32.1%	Shares	Sole	2024-11-14
2024-06-30	$290,784	34,494	-68.2%	Shares	Sole	2024-08-13
2024-03-31	$729,025	108,486	+128.1%	Shares	Sole	2024-05-08
2023-12-31	$279,705	47,569	+43.3%	Shares	Sole	2024-02-14
2023-09-30	$323,729	33,203	-12.6%	Shares	Sole	2023-11-13
2023-06-30	$449,766	37,987	-16.1%	Shares	Sole	2023-08-10
2023-03-31	$488,376	45,262	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.